DuPont de Nemours, Inc. CapEx decreased by 13.6% to $102.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.4%, from $122.00M to $102.00M.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $216.00M | $208.00M | $81.00M | $251.00M | $96.00M | $155.00M | $160.00M | $232.00M | $123.00M | $119.00M | $207.00M | $102.00M | $67.00M | $122.00M | $243.00M | $118.00M | $102.00M |
| QoQ Change | — | -3.7% | -61.1% | +209.9% | -61.8% | +61.5% | +3.2% | +45.0% | -47.0% | -3.3% | +73.9% | -50.7% | -34.3% | +82.1% | +99.2% | -51.4% | -13.6% |
| YoY Change | — | — | — | — | -55.6% | -25.5% | +97.5% | -7.6% | +28.1% | -23.2% | -10.8% | -17.1% | -43.7% | -41.1% | +138.2% | +76.1% | -16.4% |